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ARIADNI ZIANNA†, MAJA SUMAR RISTOVIC†‡, GEORGE PSOMAS†, ANTONIS HATZIDIMITRIOU†, 
EVDOXIA COUTOULI-ARGYROPOULOU§ and MARIA LALIA-KANTOURI*† 
 
†Department of General and Inorganic Chemistry, Faculty of Chemistry, Aristotle University of Thessaloniki, 
GR-54124 Thessaloniki, Greece 
‡Faculty of Chemistry, University of Belgrade, Studenski trg 12-16, Belgrade, Serbia 
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Five Cd(II) complexes with the anion of 5–NO2–salicylaldehydeH (5–NO2–saloH) in the 
absence or presence of the α–diimine 1,10–phenanthroline (phen), 2,2’–dipyridylamine 
(dpamH), 2,2’–dipyridine (bipy) or 2,9–dimethyl–1,10–phenanthroline (neoc) were synthesized 
and characterized as [Cd(5–NO2–salo)2(CH3OH)2] (1), [Cd(5–NO2–salo)2(phen)]·2CH3OH∙H2O 
(2), [Cd(5–NO2–salo)2(dpamΗ)] (3), [Cd3(5–NO2–salo)6(bipy)2] (4) and [Cd(5–NO2–
salo)(neoc)(NO3)]2 (5). Based on spectroscopic results (IR, UV, NMR), elemental analysis and 
conductivity measurements an octahedral geometry around cadmium metal ion is suggested, with 
the 5–NO2–salicylaldehyde ligand having different coordination modes. The structures 
determined by X-ray crystallography verified neutral mononuclear 1-3 and trinuclear 4. 
Simultaneous TG/DTG-DTA technique was used to analyze the thermal behavior of 1, 2 and 3. 
The complexes bind tightly to calf-thymus DNA mainly by intercalation, as concluded by DNA-
viscosity measurements and exhibit significant displacement of EB from the EB-DNA complex. 
 
Keywords: Cadmium(II) complexes; Crystal structure; Interaction with DNA 
 
1. Introduction 
Cadmium is considered a human carcinogen by the International Agency for Research on 
Cancer. Cadmium can induce cancer by a number of mechanisms, the most important among 
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 them are aberrant gene expression, inhibition of DNA damage repair, induction of oxidative 
stress, and inhibition of apoptosis [1]. Cadmium accumulates in the human body with a long 
half-life and its targets of toxicity include bone, cardiovascular system, immune system, liver, 
lung and kidney [2]. These drawbacks limit research on this metal, but complexes with 
antimicrobial [3, 4], as well as antibacterial/antifungal properties have been reported [5]. In 
addition, there have been studies regarding the cytotoxic activity of a dinuclear Cd(II) complex 
[6], as well as Cd(II) complexes with antiproliferative [7, 8] and cancer cell inhibitory properties 
[9]. 
The interaction of transition metal complexes with DNA has been in the center of 
scientific interest for many years, mainly due to their potential applications in cancer research 
and molecular biology [10, 11] and among other metal complexes with more bio–compatible 
metals; the ability of cadmium complexes to bind to DNA has also been investigated [12-18]. 
The strong coordinating properties of 2–hydroxy–benzaldehyde (salicylaldehyde) and its 
complexes with 3d transition metals have stimulated research on these compounds that find 
applications in both pure [19, 20] and applied chemistry [21, 22]. It has also been shown that 
these ligands possess antimicrobial properties [23, 24]. These ligands coordinate mainly in a 
bidentate manner with transition metals in the mono–anionic form, adopting geometries from 
square–planar [25] to square–pyramidal [26] and octahedral [27]. 
We have initiated in our laboratory the synthesis and characterization of transition metal 
complexes with carbonyl compounds derived from salicylaldehyde and benzophenone ligands 
[28-34]. Our interest is based on the synthesis of metal complexes with substituted 
salicylaldehydes and their interaction with DNA. Previous studies showed that zinc(II) and 
copper(II) complexes with substituted salicylaldehydes or 2–hydroxybenzophenones have 
interesting binding to calf–thymus (CT) DNA [32, 33, 35], while Co(II) complexes in the 
presence of the nitrogen–donor ligand 2,2’–dipyridylamine (dpamH) exhibited anticancer 
activity [31]. 
As continuation of our research, we synthesized and characterized cadmium(II) 
complexes with the ligand HL = 5–nitro–2–hydroxy–benzaldehyde (5–nitro–salicylaldehyde, 
abbreviated as 5–NO2–saloH) in the absence [Cd(5–NO2–salo)2(CH3OH)2] (1), or presence of α-
diimines 2,2’–dipyridine (bipy), dpamH, 1,10–phenanthroline (phen) and 2,9–dimethyl–1,10-
phenanthroline or neocuproine (neoc) (scheme 1). These compounds gave different structures 
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 according to the α–diimine used. Their characterization was achieved by physicochemical 
measurements and spectroscopic methods (IR, UV–vis, 1H– and 13C–NMR) and formulated as 
[Cd(5–NO2–salo)2(phen)]·2CH3OH∙H2O (2), [Cd(5–NO2–salo)2(dpamΗ)] (3), [Cd3(5–NO2–
salo)6(bipy)2] (4) and [Cd(5–NO2–salo)(neoc)(NO3)]2 (5). The crystal structures of 1-4 were 
verified by single–crystal X–ray diffraction analysis. The thermal stabilities for 1-3 were 
investigated by simultaneous (TG/DTG-DTA) technique. The ability of the complexes to bind to 
calf-thymus DNA (CT DNA) has been investigated by: (i) UV spectroscopic titration studies and 
the binding constants to CT DNA, Kb, have been determined, (ii) measurements of the viscosity 
of DNA solution in the presence of increasing amounts of 1-5 and (iii) competitive binding 
titration with the classic intercalator ethidium bromide (EB) performed by fluorescence 
spectroscopy in order to assess the ability of the compounds to displace EB from the EB-DNA 
complex as indirect proof of a potential intercalative binding mode. 
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Scheme 1. The formula of (A) 5–NO2–saloH, (B) bipy, (C) dpamH, (D) phen and (E) neoc with 
the H atom numbering. 
 
2. Experimental 
2.1. Materials - Instrumentation – Physical measurements 
The α–diimines (bipy, dpamH, phen and neoc), 5–NO2–saloH, Cd(NO3)2∙4H2O, CH3ONa, 
trisodium citrate, NaCl, CT DNA and EB were obtained as reagent grade from Sigma–Aldrich 
Co. and were used as received. Solvents for the preparation and physical measurements of “extra 
pure” grade were obtained from Chemlab without further purification. 
The DNA stock solution was prepared by dilution of CT DNA to buffer (containing 
150 mM NaCl and 15 mM trisodium citrate at pH 7.0) followed by exhaustive stirring for three 
days, and kept at 4 °C for no longer than a week. The stock solution of CT DNA gave a value of 
A260/A280 (ratio of UV absorbance at 260 and 280 nm) equal to 1.85, indicating that the DNA 
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 was sufficiently free of protein contamination [36]. The DNA concentration was determined by 
the UV absorbance at 260 nm after 1:20 dilution using ε = 6600 M–1cm–1 [37]. 
The infrared (IR) spectra (400–4000 cm−1) were recorded on a Nicolet FT–IR 6700 
spectrometer with samples prepared as KBr pellets. The UV–visible (UV–vis) spectra were 
recorded as nujol mulls and in DMSO solutions at concentrations from 10
−5–10−3 M on a Hitachi 
U–2001 dual beam spectrophotometer. 1H–NMR and 13C–NMR spectra were recorded at 300 
MHz and 75 MHz, respectively, on a Bruker AVANCE
III
 300 spectrometer using DMSO–d6 as 
solvent. C, H and N elemental analyses were performed on a Perkin Elmer 240B elemental 
microanalyzer. Molecular conductivity measurements of 1 mM DMSO solution of the complexes 
were carried out with a Crison Basic 30 conductometer. Fluorescence spectra were recorded in 
solution on a Hitachi F–7000 fluorescence spectrophotometer. Viscosity experiments were 
carried out using an ALPHA L Fungilab rotational viscometer equipped with an 18 mL LCP 
spindle and the measurements were performed at 100 rpm. The simultaneous TG/DTG-DTA 
curves were recorded on a SETARAM thermal analyzer, model SETARAM SETSYS–1200. The 
samples of approximately 10 mg were heated in platinum crucibles, in a nitrogen atmosphere at a 
flow rate of 50 mL min 
-1
, from 30–900 °C at a heating rate of 10 °C min-1. 
 
2.2. Synthesis of the complexes 
2.2.1. Synthesis of [Cd(5–NO2–saloH)2(CH3OH)2] (1). Complex 1 was prepared according to 
the published procedure [38], by addition of a methanolic solution (20 mL) of 5–NO2–saloH 
(1 mmol, 167 mg), deprotonated with CH3ONa (1 mmol, 54 mg), to a methanolic solution 
(20 mL) of Cd(NO3)2∙4H2O (0.5 mmol, 154 mg) at room temperature. The reaction mixture was 
heated at 50 °C, stirred for 1 h turning yellow. The reaction solution was left to stand at room 
temperature for slow evaporation and after a few days, yellow crystals suitable for X-ray 
structure determination were collected with filtration and air–dried. Yield 53.0%, 270 mg, 
analyzed as [Cd(5–NO2–salo)2(CH3OH)2], (C16H16Cd1N2O10) (MW=508.71): C, 37.78; H, 3.71; 
N, 5.51. Found: C, 37.80; H, 3.70; N, 5.52. IR spectrum (KBr): selected peaks in cm
–1
: 3437 
(medium, (m) v(O–H) of coordinated methanol, 1641 (strong, (s)) v(C=O), 1325 (strong–to–
medium (sm)) v(C–O→Cd), 494 (m) v(Cd–O); UV–vis: λ/nm (ε/M−1cm−1) as nujol mull: 370, 
428; in DMSO: 373 (3270), 432 (5800); molar conductivity in 1 mM DMSO = 15.0 μS/cm. 
1
HNMR (300 MHz) spectrum in DMSO–d6 (δ/ppm): 9.88 (2H, s, H
7
 5–NO2–salo), 8.29 (2H, d, 
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 J = 3.2 Hz, H
6
 5NO2–salo), 7.91 (2H, dd, J = 9.6, 3.2 Hz, H
4
 5–NO2–salo), 6.48 (2H, d, J = 
9.6 Hz, H
3
 5NO2–salo). 
13
C–NMR (75 MHz) spectrum in DMSO–d6 (δ/ppm): 192.5, 179.2, 
131.5, 129.3, 129.1, 125.0, 122.3. 
 
2.2.2. Synthesis of the cadmium mixed–ligand complexes (2-5). The reaction of a methanolic 
solution of Cd(NO3)2∙4H2O with quantities of 5–NO2–saloH in methanol (deprotonated by 
sodium methoxide) and an α–diimine (bipy, phen, neoc, dpamH) led to the preparation of 
mixed–ligand cadmium complexes (2-5). 
[Cd(5–NO2–salo)2(phen)]·2CH3OH∙H2O (2). Complex 2 was prepared by addition of a 
methanolic solution (15 mL) of 5–NO2–saloH (1 mmol, 157 mg) deprotonated with CH3ONa 
(1 mmol, 54 mg) to a methanolic solution (10 mL) of Cd(NO3)2∙4H2O (0.5 mmol, 154 mg) and 
phen (0.5 mmol, 90 mg). The reaction mixture was stirred for two hours at 50 °C and left for 
slow evaporation. Yellow crystals suitable for X–ray structure determination, yield 51.0%, 
361 mg, analyzed as [Cd(5–NO2–salo)2(phen)]·2MeOH
.
H2O (C28H26Cd1N4O11) (MW=706.93): 
C, 47.57; H, 3.71; N, 7.92. Found: C, 47.59; H, 3.72; N, 7.90. IR spectrum (KBr): selected peaks 
in cm
–1
: 3432 (m) v(O–H) of crystalized methanol and H2O, 1647(s) and 1603(s) v(C=O), 
1541(sm) ν(C=N), 1323(sm) v(C–O→Cd), 836(m), 756(m) and 723(sm) δ(C–H)phen, 529(m) 
v(Cd–O); 478(m) v(Cd–N); UV–vis: λ/nm as nujol mull: 375, 427; in DMSO: 373 (3630), 432 
(4710); molar conductivity in 1 mM DMSO = 25.0 μS/cm. 1H–NMR (300 Hz) spectrum in 
DMSO–d6 (δ/ppm): 10.08 (2H, s, H
7
 5–NO2–salo), 8.28 (2H, d, J = 3.2 Hz, H
6
 5–NO2–salo), 
7.95 (2H, dd, J = 9.5, 3.2 Hz, H
4
 5–NO2–salo), 6.57 (2H, d, J = 9.5 Hz, H
3
 5–NO2–salo) and 9.07 
(2H, d, J = 4.3 Hz, H
2
 and H
9
 phen), 8.87 (2H, d, J = 8.2 Hz, H
4
 and H
7
 phen), 8.25 (2H, s, 
H
5
 and H
6
 phen), 8.04 (2H, dd, J = 8.2, 4.3 Hz, H
3
 and H
8
 phen). 
13
C–NMR (75 MHz) spectrum 
in DMSO–d6 (δ/ppm): 191.0, 176.2, 150.0, 148.9, 139.8, 133.1, 129.5, 128.9, 128.2, 127.2, 
125.4, 123.2, 122.4. 
[Cd(5–NO2–salo)2(dpamΗ)] (3). Yellow crystals suitable for X–ray structure 
determination, yield 57.0%, 351 mg, analyzed as [Cd(5–NO2–salo)2(dpamΗ)], (C24H17CdN5O8) 
(MW=615.83): C, 46.81; H, 2.78; N, 11.37. Found: C, 46.85; H, 2.79; N, 11.36. IR spectrum 
(KBr): selected peaks in cm
–1
: 3309, 3243 and 3195 (weak, (w)) v(N–H)dpamH, 1649(s) 
δ(NH)dpamH, 1649(s) v(C=O), 1601(m) ν(C=N), 1322(sm) v(C–O→Cd), 837(m), 766(m), 
722(m), δ(C–H)dpamH, 523(m) v(Cd–O); 482(m) v(Cd–N); UV–vis: λ/nm (ε/M
−1
cm
−1
) as nujol 
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 mulls: 368, 427; in DMSO: 370 (3200), 430 (5400); molar conductivity in 1 mM DMSO = 
35.0 μS/cm. 1H–NMR (300 MHz) spectrum in DMSO-d6 (δ/ppm): 10.10 (1H, s, H
7
 5–NO2–
salo), 8.33 (1H, d, J = 3.1 Hz, H
6
 5-NO2-salo), 8.05 (1H, dd, J = 9.4 Hz, 3.1 Hz, H
4
 5-NO2-salo), 
6.69 (1H, d, J = 9.4 Hz, H
3
 5-NO2-salo) and 9.59 (1H, H
7
 dpmaH), 8.19 (2H, d, J = 4.9 Hz, 
H
3
 and H
3′
 dpamH), 7.60-7.68 (4H, m, H
5
, H
5′
, H
6
, H
6′
 dpamH), 6.84-6.90 (2H, m, H
4
 and H
4′
 
dpamH). 
13
C–NMR (75 MHz) spectrum in DMSO–d6 (δ/ppm): 191.0, 174.4, 154.3, 147.1, 137.7, 
134.3, 129.8, 127.4, 122.6, 122.4, 115.9, 112.1. 
[Cd3(5–NO2–salo)6(bipy)2] (4). The formed yellow crystals suitable for X–ray structure 
determination, yield 51.0%, 839 mg, analyzed as [Cd3(5–NO2–salo)6(bipy)2], (C62H40Cd3N10O24) 
(MW=1646.14): C, 45.24; H, 2.45; N, 8.51; C, 45.48; H, 2.49; N, 8.53. IR spectrum (KBr): 
selected peaks in cm
-1
: 1676, 1647 and (s) v(C=O), 1603(s) ν(C=N), 1343(sm) v(C–O→Cd), 
833(m), 762(sm), 720(m) δ(C-H)pyridyl, 526(m) v(Cd–O), 478(m) v(Cd–N); UV–vis: λ/nm 
(ε/M−1cm−1) as nujol mull: 374, 428; in DMSO: 373 (2500), 431 (3100); molar conductivity in 
1 mM DMSO = 25.2 μS/cm. 1H–NMR (300 MHz) spectrum in DMSO–d6 (δ/ppm): 10.08 (6H, s, 
H
7
 5–NO2–salo), 8.28 (6H, d, J = 3.2 Hz, H
6
 5–NO2–salo), 7.89 (6H, dd, J = 9.6 Hz, 3.2 Hz, 
H
4
 5–NO2–salo), 6.48 (6H, d, J = 9.6 Hz, H
3
 5–NO2–salo) and 8.71 (4H, d, J = 4.2 Hz, H
3– and 
H
3′–bipy), 8.51 (4H, d, J = 8.0 Hz, H6–and H6′–bipy), 8.11 (4H, dd as t, J = 7.6 Hz, H5– and 
H
5′bipy), 7.62 (4H, dd as t, J = 6.1 Hz, H4– and H4′–bipy). 13C–NMR (75 MHz) spectrum in 
DMSO–d6 (δ/ppm): 192.1, 179.4, 151.8, 149.2, 139.1, 131.4, 129.3, 128.6, 125.4, 124.9, 122.4, 
121.7. 
[Cd(5–NO2–salo)(neoc)(NO3)]2 (5). Yellow solid, yield 50.0%, 549 mg, analyzed as 
[Cd(5–NO2–salo)(neoc)(NO3)]2, (C42H32Cd2N8O14) (MW=1097.58): C, 45.96; H, 2.94; N, 10.21. 
Found: C, 45.91; H, 2.95; N, 10.11. IR spectrum (KBr): selected peaks in cm
–1
: 1652(s) v(C=O), 
1597(m) ν(C=N), 1315(sm) v(C–O→Cd), 860(m), 761(m) and 730(sm) δ(C–H)neoc, 550(m) 
v(Cd–O); 476(m) v(Cd–N); UV–vis: λ/nm (ε/M−1cm−1) as nujol mulls: 370, 428; in DMSO: 373 
(2700), 431 (4730); molar conductivity in 1 mM DMSO = 24.7 μS/cm. 1H–NMR (300 MHz) 
spectrum in DMSO–d6 (δ/ppm): 9.78 (1H, s, H
7
 5–NO2–salo), 8.30 (1H, d, J = 3.1 Hz, 
H
6
 5NO2–salo), 7.93-7.87 (3H, m, overlapped H
4
 5–NO2–salo and H
3
 H
8
 neoc), 6.45 (1H d, J = 
9.6 Hz, 5–NO2–salo) and 8.64 (2H, d, J = 8.3 Hz, H
4
 and H
7
 neoc), 8.07 (2H, s, H
5
 and H
6
 neoc), 
2.98 (6H, s, CH3 neoc). 
13
C–NMR (75 MHz) spectrum in DMSO–d6 (δ/ppm): 193.6, 178.7, 
159.8, 140.6, 139.2, 132.3, 130.1, 129.6, 127.1, 126.0, 125.7, 124.8, 122.0, 25.0. 
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2.3. X–ray crystal structure determination 
Single crystals of [Cd(5–NO2–salo)2(CH3OH)2] (1), [Cd(5–NO2–salo)2(phen)]·2CH3OH∙H2O (2), 
[Cd(5–NO2–salo)2(dpamΗ)] (3) and [Cd3(5–NO2–salo)6(bipy)2] (4), suitable for crystal structure 
analysis, were obtained by slow evaporation of their mother liquids at room temperature. They 
were mounted at room temperature on a Bruker Kappa APEX2 diffractometer equipped with a 
triumph monochromator using Mo Kα radiation. Unit cell dimensions were determined and 
refined by using the angular settings of at least 200 high intensity reflections (>10 σ(I)) in the 
range 11 < 2θ < 36°. Intensity data were recorded using  and ω scans. All crystals presented no 
decay during the data collection. The frames collected for each crystal were integrated with the 
Bruker SAINT Software package [39] using a narrow-frame algorithm. Data were corrected for 
absorption using the numerical method (SADABS) based on crystal dimensions [40]. All 
structures were solved using the SUPERFLIP package [41], incorporated in Crystals. Data 
refinement (full–matrix least–squares methods on F2) and all subsequent calculations were 
carried out using the Crystals version 14.40b program package [42]. All non-hydrogen atoms 
were refined anisotropically. Hydrogens were located by difference maps at their expected 
positions and refined using soft constraints. By the end of the refinement, they were positioned 
geometrically using riding constraints to bonded atoms. Illustrations with 50% ellipsoids 
probability were drawn by CAMERON [43]. Crystal data for 1-4 are provided in table 1. 
 
2.4. DNA-binding studies 
In order to study the interaction of DNA with 1-5, the compounds were initially dissolved in 
DMSO (1 mM). Mixing of such solutions with the aqueous buffer DNA solutions used in the 
studies never exceeded 5% DMSO (v/v) in the final solution, which was needed due to low 
aqueous solubility of most compounds. All studies were performed at room temperature. The 
interaction of free 5–ΝΟ2–saloH with CT DNA was recently reported [32]. 
Study with UV spectroscopy. The interaction of 1-5 with CT DNA was studied by UV 
spectroscopy in order to investigate the possible binding modes to CT DNA and to calculate the 
binding constants to CT DNA (Kb). Control experiments with 5% DMSO were performed and no 
changes in the spectra of CT DNA were observed. The UV spectra of CT DNA in the presence 
of each compound were recorded for a constant CT DNA concentration in diverse mixing ratios 
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 (r=[compound]/[DNA]). The binding constant of the compounds with DNA, Kb (in M
–1
), were 
determined by the Wolfe–Shimer equation (eq. S1) [44] and the plots 
)(
]DNA[
fA 
 vs [DNA] using 
the UV spectra of the compounds recorded, for a constant concentration in the presence of DNA 
at diverse ratios (r’ = [DNA]/[compound]). 
Viscometry. Viscosity experiments were carried out using an ALPHA L Fungilab 
rotational viscometer equipped with an 18 mL LCP spindle and the measurements were 
performed at 100 rpm. The viscosity of DNA ([DNA] = 0.1 mM) in buffer solution (150 mM 
NaCl and 15 mM trisodium citrate at pH 7.0) was measured in the presence of increasing 
amounts of 1-5 up to r = 0.35. All measurements were performed at room temperature. The 
obtained data are presented as (η/η0)
1/3
 versus r, where η is the viscosity of DNA in the presence 
of the compound and η0 is the viscosity of DNA alone in buffer solution. 
EB competitive studies with fluorescence spectroscopy. Competitive studies of each 
compound with EB were investigated with fluorescence spectroscopy in order to examine 
whether the compound can displace EB from its DNA–EB complex. The DNA–EB complex was 
prepared by adding 20 µM EB and 26 µM CT DNA in buffer (150 mM NaCl and 15 mM 
trisodium citrate at pH 7.0). The possible intercalating effect of the compounds (5–ΝΟ2–saloH 
and 1-5) was studied by adding a certain amount of a solution of the compound step by step into 
a solution of the pre–treated DNA–EB complex. The influence of the addition of each compound 
to the DNA–EB complex solution has been obtained by recording the variation of fluorescence 
emission spectra with excitation wavelength at 540 nm. The compounds do not show any 
fluorescence emission at room temperature in solution or in the presence of DNA under the same 
experimental conditions; therefore, the observed quenching is attributed to the displacement of 
EB from its EB–DNA complex. The values of the Stern–Volmer constant (KSV, in M
–1
) have 
been calculated according to the linear Stern–Volmer equation (eq. S2) [45, 46] and the 
corresponding plots. 
 
3. Results and discussion 
3.1. Synthesis–general considerations of the complexes 
The reaction of Cd(NO3)2∙4H2O with deprotonated 5–NO2–saloH in methanol afforded solid 
microcrystalline compound in good yield, according to reaction (1). 
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 Cd(NO3)2∙4H2O + 2 (5–NO2–saloH) + 2 CH3ONa → 
 [Cd(5–NO2–salo)2(CH3OH)2] + 2 NaNO3 + 4 H2O (1) 
 
The resultant cadmium(II) complex [Cd(5–NO2–salo)2(CH3OH)2] (1) is neutral (molar 
conductivity in DMSO solution was 15.0 μS∙cm–1) and possesses a 1:2 metal–to–ligand 
composition, as it is indicated from elemental analysis. It is soluble in CH3OH, DMF and 
DMSO, but not in CH3CN, CH3COCH3, CH2Cl2, EtOH, H2O and Et2O.  
The reaction of methanolic solutions of Cd(NO3)2∙4H2O, 5–NO2–saloH and an α–diimine 
(bipy, phen, neoc, dpamH) led to complexes 2-5, respectively, with three different formulas and 
coordination modes of 5–NO2–salo
–
, depending on the α–diimine used, as following: 
Cd(NO3)2∙4H2O + 2 (5–NO2–saloH) + 2 CH3ONa + α–diimine (phen or dpamH) → 
[Cd(5–NO2–salo)2(α–diimine)] (2 or 3), [Cd3(5–NO2–salo)6(bipy)2] (4) and [Cd(5–NO2–
salo)(neoc)(NO3)]2 (5). 
The synthesized cadmium(II) complexes are neutral, soluble in DMF and DMSO, but 
insoluble in most organic solvents and H2O. Evidence of the coordination mode of the ligands in 
the cadmium compounds has also arisen from the interpretation of the IR, UV, 
1
H– and 
13
CNMR data of the 5–nitro–salicylaldehyde, the α–diimines and the complexes. In these 
compounds, the α–diimine is coordinated as a neutral bidentate ligand through the heterocyclic 
nitrogens, while 5–nitro–salicylaldehyde behaves as a monoanionic ligand, coordinated to 
cadmium ion through the phenolato oxygen in all complexes, but bidentate and/or tridentate in 
different complexes, as will be clarified by spectroscopy and X–ray crystallography. 
 
3.2. Spectroscopy (IR, UV–vis, 1H– and 13C–NMR) 
IR spectroscopy was used to confirm the deprotonation and the binding mode of 5–NO2–saloH 
as well as the binding modes of the α–diimines. In the IR spectra of the complexes, the peaks of 
the stretching and bending vibrational modes of the phenolic OH of 5–NO2–saloH found around 
3200 cm
–1
 and 1400 cm
–1
 in the IR spectrum of free 5–NO2–saloH, respectively, disappear 
indicating deprotonation of the salicylaldehyde [47, 48]. Additionally, the peak originating from 
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 the C–O stretching vibration at 1276 cm–1 in the complexes exhibits positive shifts to ~1300 cm–1 
denoting coordination through the deprotonated phenolic oxygen. 
The peak at ~1660 cm
–1
, attributable to the aldehyde bond v(HC=O) of the free 5–NO2–
saloH, is shifted to lower frequencies (~1630 cm
–1
) in the complexes, thus denoting the bidentate 
mono–anionic character of the ligand [49]. This is valid for 1, 4 and 5. However, for 2 and 3 with 
bipy and phen, respectively, besides the peak at 1630 cm
–1
, there is an additional peak at 
~1660 cm
–1
, which denotes the presence of non–coordinated aldehyde oxygen of salicylaldehyde 
ligand in these complexes. 
The intense bands at ~1590 cm
–1
 attributed to the stretching vibrations v(C=N)aromatic are 
present in the mixed–ligand complexes, denoting coordination through the nitrogens of the 
αdiimine ligands. The IR spectrum of 5 demonstrates also the presence of coordinated nitrates. 
Two strong bands at 1488–1502 cm–1 and 1288–1302 cm–1, assigned to the v4 and v1 vibrations 
of nitrate, respectively (C2V symmetry, coordinated nitrate). The magnitude of the splitting Δ, 
where Δ = v4–v1, is ~136 cm
–1
 and it is typical of monodentate (M–O–NO2) bonding of nitrates 
[50]. 
1
H–NMR spectroscopy was also used in order to confirm deprotonation of the 
salicylaldehyde and the stability of the complexes in solution. The deprotonation of the phenolic 
hydrogen can be easily concluded from the absence of the –OH signal, which is observed in the 
1
H–NMR spectra of the free 5–NO2–saloH, appearing as single peak at δ = 12 ppm. The 
1
HNMR spectra of 1-5 are consistent with the obtained structures. All the expected signals 
related to the presence of the ligands in the corresponding compounds are present; four signals 
for the 5–NO2–salo
 
and four for the a–diimine ligands, as shown representatively for 2 and 4 in 
figure 1. From the number of protons in the 
1
H–NMR spectra of the complexes, we conclude that 
the ratio of 5–NO2–salicylaldehyde to a–diimine is 2:1 in 2 and 3, 3:1 in 4 and 1:1 in 5. All 
signals are slightly shifted as expected upon binding to cadmium ion. The 
1
H–NMR spectra of 
the complexes give the protons, attributable to the aldehydo group at δ 9.78-10.10 ppm. 
13
CNMR spectra give also the expected sets of chemical shifts for both the 5–NO2–salo and the 
diimine moieties; seven peaks for 5–NO2–salo
-
 and five or six for the diimine. The most 
characteristic peaks are that of carbonyl carbon at δ 193.6-191.0 ppm and C-2 of 5–NO2–salo at 
δ = 179.4-174.4 ppm. The absence of additional set of signals related to dissociated ligands 
suggests that all complexes remain intact in solution. 
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 The UV spectra of the complexes were recorded as nujol mull and in DMSO solution and 
are similar, suggesting that the complexes retain their structure in solution. In addition, the UV 
spectra of the complexes were also recorded in the series of pH (pH range 6–8, since the 
biological experiments are performed at pH = 7) with the use of diverse buffer solutions 
(150 mM NaCl and 15 mM trisodium citrate at pH values regulated by HCl solution) so as to 
explore the stability of complexes in buffer solution; no significant changes (shift of the λmax or 
new peaks) were observed in the spectra of 1-5, indicating that they may keep their integrity in 
the pH range 6–8 [51, 52].  
The fact that the complexes are non–electrolytes in DMSO solution (ΛM = 15–35 mho 
cm
2 
mol
–1
, in 1 mM DMSO solution) having similar UV spectral patterns in nujol, in DMSO 
solution and in the presence of the buffer solution and that their 
1
H–NMR spectra confirm no 
dissociation, may suggest that the compounds are stable in DMSO solution [53]. 
 
3.3. Description of the structures 
The molecular structures of 1-4 with the atom numbering scheme are shown in figures 2-4, 
respectively, and selected bond distances and angles are given in table 2. 
 
3.3.1. Description of the structure of [Cd(5–NO2–salo)2(CH3OH)2] (1). In the molecular 
structure of [Cd(5–NO2–salo)2(CH3OH)2] (1), two 5–NO2–salicylaldehyde anions are chelated 
through the phenolate oxygen (O1) and the carbonyl (O2) to the cadmium cation in trans-
positions and occupy the equatorial plane. In 1, as well as in 2 and 3, the Cd–(O1) (phenolic 
oxygen) distance is shorter than the Cd–(O2) (carbonyl oxygen) distance, as expected, 
suggesting stronger coordination ability of the ionic phenolate oxygen (table 2). A slightly 
distorted octahedral coordination is achieved by binding of two methanol molecules in the axial 
positions (figure 2). The mean planes of the two salicylaldehyde ligands in the same complex are 
parallel but not co–planar having a distance of 1.574 Å. The Cd(II) ion is situated in the mid 
distance due to symmetry reasons. Strong intermolecular hydrogen bonding interactions arise 
from the methanol hydroxyl groups to the phenolate O forming chains of complex planes parallel 
to ‘a’ crystallographic axis. Bond distances of coordinated 5–NO2–salicylaldehyde are similar to 
a reported mixed–ligand 5–NO2–salicylaldehydato copper(II) complex [54]. 
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 3.3.2. Description of the structures of [Cd(5–NO2–salo)2(α–diimine)] (2 and 3, phen and 
dpamH, respectively). The complexes [Cd(5–NO2–salo)2(phen)]·2CH3OH∙H2O (2) and 
[Cd(5NO2–salo)2(dpamH)] (3) have similar structures. One phenanthroline (phen) or 
dipyridylamine (dpamH) is coordinated in a bidentate manner (through two pyridine nitrogens as 
a neutral ligand) forming a five-membered chelate ring with the cadmium ion, while two 
5NO2–salo monoanionic ligands are coordinated to the cadmium cation in a chelating bidentate 
way (through the deprotonated phenolic and the carbonyl oxygen atoms), forming a six-
membered ring (figure 3). The cadmium ion is six-coordinate and its geometry octahedral with a 
CdΟ4Ν2 chromophore. The structure of 3 is stabilized by ΝamΗ...Οphenolic type hydrogen-bonds 
between two neighboring complex molecules forming complex dimers. Hydrogen-bonding in 2 
arises only between methanol and water molecules. 
 
3.3.3. Description of the structure of [Cd3(5–NO2–salo)6(bipy)2] (4). In [Cd3(5–NO2–
salo)6(bipy)2] (4), the six deprotonated 5–NO2–salo
–
 ligands are coordinated in three different 
modes: (i) as a bidentate ligand bridging two cadmium cations Cd1 and Cd2 through only the 
phenolic O9, (ii) as a bidentate chelating anion through the phenolic O1 and the aldehydo O2 
bounded to the terminal cadmium cations Cd1 and (iii) as a tridentate ligand, i.e. chelating the 
central cadmium Cd2 through the phenolic O5 and the aldehydo O6 and bridging via O5 to 
central and one terminal cadmium Cd1. To the best of our knowledge, this is the first time that 
such combination of coordination modes of the same substituted salicyladehyde in the same 
compound is reported. The average Cd–Ophenolic distance is comparable to those found in other 
trinuclear cadmium complexes with Schiff bases [55]. The central cadmium ion has a CdΟ6 
chromophore and octahedral geometry. The four coordinated oxygens are monodentate bridging 
phenolic oxygens and aldehydo oxygens. The two terminal cadmium cations are six-coordinate 
having a distorted octahedral geometry. Besides the four oxygens from 5–NO2–salo
–
 ligands 
(one is aldehydo, one monodentate phenolic and two bridging phenolic), their coordination 
sphere is completed by two nitrogens (N4 and N5) from the bipy ligands giving a CdΟ4Ν2 
chromophore. The Cd–N distances are within the expected limits [56]. The distance between the 
two cadmium ions is Cd1…Cd2 = 3.588(5) Å. 
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 3.4. Thermal investigation 
The thermal stabilities and decomposition modes of 1-3 were investigated by the simultaneous 
TG/DTG/DTA technique, in nitrogen atmosphere with heating rate 10 °C min
-1
, from ambient to 
900 °C. The profiles of their thermoanalytical curves reveal complicated decomposition, in 
connection with the release of the ligand molecules, as depicted in figure 5 for 1 and 2. The 
release of coordinated methanol in 1 or crystallized methanol in 2 takes place first in both 
compounds. Then follows the decomposition of the ligand and finally for 2 the decomposition of 
1,10-phenanthroline. In both cases the residue at 900 °C consists of a mixture of carbonaceous 
metal along with cadmium oxide CdO. 
 
3.5. Interaction with calf–thymus DNA 
The interaction of transition metal complexes with DNA mainly depends on the structure and the 
nature of the coordinated ligands. Thus, transition metal complexes may interact with double–
stranded DNA via: (i) covalent bonding, via the replacement of one or more labile ligands by a 
nitrogen base of DNA, (ii) non–covalent mode, i.e. (a) intercalation of the complex between 
DNA nucleobases via ππ stacking interactions, (b) electrostatic interactions between metal 
complexes and the phosphate groups of DNA when Coulomb forces may develop, and 
(c) groove–binding due to the presence of van der Waals forces or hydrogen–bonding or 
hydrophobic bonding along the major or minor groove of the DNA helix, and (iii) cleavage of 
the DNA helix along and/or across its length [57]. 
 
3.5.1. UV spectroscopy and DNA-interaction. UV–Vis spectroscopy is a useful tool to provide 
information in regard to mode and strength of binding of compounds with DNA. The existence 
of any interaction between the compound and CT DNA will perturb the band of CT DNA at 
258–260 nm or the intra–ligand transition bands of the compound, respectively, during the 
titrations. Red–shift shows stabilization of the structure because of the interaction; blue–shift is 
evidence of structural destabilization. Furthermore, the intense hypochromism of a transition 
band, which is usually accompanied by bathochromism, is clear evidence of an intercalative 
binding mode [58]. In particular, the UV spectra of a CT DNA solution (1.0–1.5 10–4 M) were 
recorded in the presence of 1-5 at increasing amounts (for different r values) as well as the UV 
D
ow
nl
oa
de
d 
by
 [P
ur
du
e U
niv
ers
ity
 L
ibr
ari
es
] a
t 2
2:0
5 0
2 N
ov
em
be
r 2
01
5 
 spectra of DMSO solution (110–5 – 510–5 M) of 1-5 in the presence of CT DNA at increasing 
amounts of r’.  
The UV spectra of DNA solution were recorded in the presence of 1-5 at increasing r 
values (up to 0.3). The UV spectra of the DNA solution in the presence of 1-5 are quite similar 
exhibiting slight hypochromism of the DNA band at 258 nm, which may be considered as 
evidence of the formation of a new adduct of the compound with double–helical DNA resulting 
in stabilization of the DNA duplex [58]. The UV spectra of DNA solution in the presence of 2 at 
diverse r values are shown in figure 6(A). 
Additionally, the UV spectra of 1-5 in DMSO (110–5 – 510–5 M) were recorded in the 
presence of CT DNA at increasing amounts. In the UV spectra of 2 (figure 6(B)), the two 
observed bands at 373 nm (band I) and 432 nm (band II) exhibit in the presence of increasing 
amounts of CT DNA a slight (~1%) and a more intense hypochromism (~12.5%), respectively, 
followed by blue-shift of up to 7 nm. Quite similar is the behavior of 1 and 3-5 in the presence of 
CT DNA which in most cases exhibit a higher hypochromism (table 3). 
It is quite evident that conclusions concerning the DNA-binding mode of the compounds 
cannot be safely drawn only by UV spectroscopic studies and more techniques should be 
combined. The data derived by the UV titration experiments suggest that all compounds can bind 
to CT DNA, while the observed hypochromism might infer the existence of intercalation [58]. 
The magnitude of the binding strength for a compound with CT DNA may be evaluated 
through calculation of the DNA–binding constant (Kb). The Kb values were obtained by plots 
)(
]DNA[
fA 
 versus [DNA] (figure S1) using the Wolfe–Shimer equation [44]. The Kb values of 
1-5 (table 3) are relatively high suggesting tight binding of the complexes to CT DNA, with 3 
having the highest Kb value (1.65(±0.10)10
6
 M
–1
) among the complexes, and are of similar 
magnitude to that of the classical intercalator EB (1.23(±0.07)105 M–1) [59]. Complexes 1-5 
have higher Kb values than their Zn analogues with 5–NO2–salo
–
 ligands [32] and are 
significantly higher than a series of Cd complexes found in the literature [12-18]. 
 
3.5.2. DNA-binding study with viscosity measurements. The viscosity of DNA (η) is sensitive 
to DNA length changes since the relation between the relative DNA-solution viscosity (η/η0) and 
DNA length (L/L0) is given by the equation (L/L0)=(η/η0)
1/3
, where L0 and L denote the apparent 
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 molecular length in the absence and presence of a compound, respectively [60, 61]. This 
characteristic is helpful when investigating the interaction of a compound with DNA. 
Intercalation (insertion of the compound in between the DNA base pairs) will result in an 
increase of the separation distance of base pairs lying at intercalation sites, causing an increase of 
the DNA-helix length which will result in an increase of DNA viscosity; the magnitude of which 
is usually in accord to the strength of the interaction. When a compound binds to DNA grooves 
via a partial or non-classic intercalation (i.e. electrostatic interaction or external groove–binding), 
a bend or kink in the DNA-helix may result in slight shortening of its effective length; in this 
case, the change in viscosity of the DNA solution is less pronounced or there is no change at all 
[60-62].  
DNA-viscosity measurements were carried out on CT DNA solutions (0.1 mM) upon 
addition of increasing amounts of the compounds (up to the value of r = 0.35) at room 
temperature. The relative viscosity of DNA solution exhibits an increase upon addition of 1-5 
which is more significant than that of free 5–NO2–saloH (figure 7). The behavior of the DNA 
viscosity observed upon addition of the compounds may be considered evidence of the existence 
of an intercalative binding mode to DNA, a conclusion which clarifies the findings from the UV 
spectroscopic titrations. 
 
3.5.3. EB–displacement studies. The excitation of a solution containing EB and DNA at 
λexcitation = 540 nm (as EB–DNA compound) results in an intense fluorescence emission band at 
~592 nm. This is due to the intercalation of the planar EB phenanthridine ring between adjacent 
DNA–base pairs, since EB is a typical DNA–intercalator. When a compound which has equal or 
higher intercalative ability towards DNA than EB is added into this solution, a significant 
quenching of the EB–DNA fluorescence emission may be induced. Complexes 1-5 do not show 
any fluorescence emission at room temperature in solution or in the presence of CT DNA under 
the same experimental conditions, i.e. λexc = 540 nm. The addition of the complexes into an EB 
solution does not quench the EB fluorescence emission and does not result in the appearance of 
new peaks in the spectra. Therefore, the changes observed in the fluorescence emission spectra 
of the EB–DNA solution, when the complexes are added, may be useful to examine the 
EBdisplacing ability of the complexes, mainly as indirect evidence and verification of their 
intercalating ability. 
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 The fluorescence emission spectra of pre–treated EB–DNA ([EB] = 20 µM, [DNA] = 
26 µM) were recorded in the presence of increasing amounts of 1-5 up to the value of r = 0.17 
(representatively shown for 1 in figure 8(A)). The addition of the complexes results in a 
significant quenching (up to 62.4–86.7%, table 4) of the initial EB–DNA fluorescence emission 
band at 592 nm (figure 8(B)), indicating significant EB–displacing ability of the complexes and, 
thus, revealing indirectly the interaction with CT DNA by intercalation [45]. 
The Stern–Volmer plots (figure S2) illustrate that the observed EB–DNA fluorescence 
emission quenching was in agreement (R = 0.99) with the linear Stern–Volmer equation (eq. S2); 
therefore, the observed quenching is a result of the displacement of EB from EB–DNA by each 
complex [32, 33]. The KSV values (table 4) of the complexes calculated by the Stern–Volmer 
equation using the Stern–Volmer plots are relatively high and suggest tight binding to DNA. In 
particular, the KSV values of most complexes are higher than that of free 5–NO2–saloH, with 1 
possessing the highest KSV value (1.41(±0.03)10
6
 M
–1
) among the complexes. Additionally, the 
KSV values of 1-5 are higher than those of their Zn analogues [32]. 
 
4. Conclusion 
The synthesis and characterization of cadmium complexes with 5–nitro–salicylaldehyde in the 
absence or presence of an α–diimine (bipy, phen, neoc or dpamH) has been achieved. The 
reaction of Cd(NO3)2∙4H2O and deprotonated 5–NO2–salicylaldehyde under aerobic conditions 
resulted in formation of [Cd(5– NO2–salo)2(CH3OH)2] (1), while the addition of the α–diimine 
(phen or dpamH) led to the formation of [Cd(5–NO2–salo)2(α-diimine)] (2 or 3), the trimeric 
[Cd3(5–NO2–salo)6(bipy)2] (4), and the dimeric [Cd(5–NO2–salo)(neoc)(NO3)]2 (5), as shown by 
spectroscopy (IR, UV-Vis and NMR), and proved by X-ray crystallography for 1-4, providing 
confirmation of different coordination modes. The thermal stability of 1-3 showed the 
complicated nature of their thermal decomposition in nitrogen. 
The interaction of 1-5 with CT DNA was explored with several techniques. UV 
spectroscopic studies revealed the ability of the complexes to bind to CT DNA. The complexes 
can bind tightly to DNA as estimated by the DNA–binding constants (Kb) with [Cd(5–NO2–
salo)2(dpamΗ)] (3), showing the highest Kb value (1.6510
6
 M
–1
) among the complexes. DNA 
viscosity measurements revealed that the probable DNA-binding mode of the complexes is 
D
ow
nl
oa
de
d 
by
 [P
ur
du
e U
niv
ers
ity
 L
ibr
ari
es
] a
t 2
2:0
5 0
2 N
ov
em
be
r 2
01
5 
 intercalation, a conclusion which was also verified by the significant ability of the complexes to 
displace the classical intercalator EB from its EB–DNA compound. 
 
Appendix A. Supplementary material 
The crystal structures of 1, 2, 3 and 4 have been submitted to the CCDC and have been allocated 
the deposition numbers CCDC 1055222-1055225, respectively. These data can be obtained free 
of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge 
Crystallographic Data Centre, 12 Union Road, Cambridge CB21EZ, UK; Fax: (+44) 1223-336-
033; or deposit@ccdc.cam.ac.uk). Supplementary data associated with this article can be found 
in the online version. 
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Table 1. Crystallographic data for 1-4. 
 1 
[Cd(5–NO2–salo)2(CH3OH)2] 
2 
[Cd(5–NO2–
salo)2(phen)]·2CH3OH∙H2O 
3 
[Cd(5–NO2–salo)2(dpamΗ)] 
4 
[Cd3(5–NO2–salo)6(bipy)2] 
Empirical formula C16H16Cd1N2O10 C28H26Cd1N4O11 C24H17Cd1N5O8 C62H40Cd3N10O24 
CCDC no. 1055222 1055223 1055224 1055225 
Molecular mass 508.71 706.93 615.83 1646.25 
Crystal system Triclinic  Orthorhombic Triclinic Triclinic 
Temperature (K) 295  295 295  295  
Radiation type Mo K Mo K Mo K Mo K 
Wavelength λ (Å) 0.71073 0.71073 0.71073 0.71073 
Space group P -1 P n n a P -1 P -1 
Unit cell dimensions 
a (Å) 
b (Å) 
c (Å) 
, deg 
, deg 
γ, deg 
 
5.1874(2)  
7.8388(3)  
11.9530(5) 
101.623(2) 
94.321(2) 
93.582(2) 
 
7.2025(3) 
20.3174(8) 
23.2505(8) 
90 
90 
90 
 
7.7970(6)  
11.3357(9)  
13.7461(12)  
95.001(3) 
98.168(3) 
90.178(3) 
 
10.5147(16) 
11.8775(19)  
13.750(2)  
100.944(10) 
106.419(9) 
107.614(11) 
Volume (Å
3
) 473.22(2)   3402.39(12) 1197.89(10) 1497.1(2) 
Z 1 4 2 1 
Absorption coeff. (μ) mm
-1
 1.213 0.700 0.972 1.153 
Crystal density, Dx, g cm
-3
 1.78 1.38 1.71 1.83 
Crystal size, mm 0.20 × 0.47 × 0.52 0.11 × 0.13 × 0.17  0.22 × 0.25 × 0.33 0.17 × 0.22 × 0.24 
θ range for data collection, 
 deg / completeness (%) 
2.661-30.687 / 99.8 1.331-32.296 / 87.1 1.502-26.478 / 99.2 1.619-26.682 / 94.5  
Range of h, k, l −7→7, −11→11, −17→17 −9→10, −28→28, −33→33 −9→9, −14→14, 0→17 −13→12, −14→14, −17→17 
Measured reflections / 18633 / 2935 / 0.0273 34036 / 5290 / 0.0239 4917 / 3526 / 0.0458 15380 / 5982 / 0.0257 
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  1 
[Cd(5–NO2–salo)2(CH3OH)2] 
2 
[Cd(5–NO2–
salo)2(phen)]·2CH3OH∙H2O 
3 
[Cd(5–NO2–salo)2(dpamΗ)] 
4 
[Cd3(5–NO2–salo)6(bipy)2] 
Independent reflections / Rint 
No. of parameters  136 197 348 448 
Goodness-of-fit 
on F
2
 (GOF) 
1.000 1.000 1.000 1.000 
Final R indices:  
R1, wR2 [I >2σ(I)] 
R1, wR2 (all data) 
 
0.0222, 0.0483 
0.0235, 0.0486 
 
0.0541, 0.0923 
0.1087, 0.1011 
 
0.0330, 0.0548 
0.0571, 0.0620 
 
0.0665, 0.1303 
0.0867, 0.1317 
Largest diff. peak / hole (e Å
-3
)  0.49 / −0.29  0.72 / −0.59 0.50 / −0.45 1.76 / –1.97 
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 Table 2. Selected bond distances (Å) and angles (°) for 1-4. 
Bond distance (Å) 1 Bond distance (Å) 2 Bond distance (Å) 3 Bond distance (Å)      4  y   4 
Cd1—O5
i
 2.2828(11) Cd1—N2
i
 2.325(3) Cd1—O1 2.254(3) Cd1—O1 2.220(6) 
Cd1—O2
i
 2.2695(12) Cd1—O2
i
 2.297(2) Cd1—O2 2.345(3) Cd1—O2 2.271(6) 
Cd1—O1
i
 2.2142(11) Cd1—O1
i
 2.244(3) Cd1—O5 2.230(3) Cd1—O5 2.333(5) 
    Cd1—O6 2.319(3) Cd1—O9 2.305(5) 
    Cd1—N3 2.273(3) Cd1—N4 2.329(7) 
Bond angle (°) 1 Bond angle (°) 2 Bond angle (°) 3 Bond angle (°) 4 
O5
i
—Cd1—O2
i
 95.47(5) N2
i
—Cd1—O2
i
 96.55(11) O1—Cd1—O2 77.47(10) O1—Cd1—O2 76.1(2) 
O5
i
—Cd1—O1
i
 90.46(4) N2
i
—Cd1—O1
i
 92.65(11) O1—Cd1—O5 161.15(8) O1—Cd1—O5 97.9(2) 
O2
i
—Cd1—O1
i
 81.26(4) O2
i
—Cd1—O1
i
 80.73(10) O2—Cd1—O5 86.77(11) O2—Cd1—O5 87.6(2) 
O5
i
—Cd1—O1 89.54(4) N2
i
—Cd1—O1 162.00(11) O1—Cd1—O6 88.02(10) O1—Cd1—O9 159.6(2) 
O2
i
—Cd1—O1 98.74(4) O2
i
—Cd1—O1 92.67(10) O2—Cd1—O6 81.27(11) O2—Cd1—O9 83.8(2) 
O1
i
—Cd1—O1 179.995 O1
i
—Cd1—O1 104.09(15) O5—Cd1—O6 79.33(10) O5—Cd1—O9 77.4(2) 
O5
i
—Cd1—O2 84.53(5) N2
i
—Cd1—O2 92.12(10) O1—Cd1—N3 99.42(12) O1—Cd1—N4 102.9(2) 
  O2
i
—Cd1—O2 169.31(14) O2—Cd1—N3 96.00(12) O2—Cd1—N4 176.7(2) 
  O1
i
—Cd1—O2 92.67(10) O5—Cd1—N3 92.38(11) O5—Cd1—N4 89.4(2) 
  O1—Cd1—O2 80.73(10) O6—Cd1—N3 171.38(11) O9—Cd1—N4 96.9(2) 
  N2
i
—Cd1—N2 71.64(15) O1—Cd1—N4 93.68(10) O1—Cd1—N5 89.0(2) 
  O2
i
—Cd1—N2 92.12(10) O2—Cd1—N4 170.95(11) O2—Cd1—N5 110.4(2) 
  O1
i
—Cd1—N2 162.00(11) O5—Cd1—N4 102.28(11) O5—Cd1—N5 161.83(19) 
  O1—Cd1—N2 92.65(11) O6—Cd1—N4 100.52(11) O9—Cd1—N5 101.5(2) 
      N4—Cd1—N5 72.7(2) 
Symmetry : __ 1.5-x, 1-y, z __ (i) -x, 1-y, -z. 
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Table 3. UV spectral features of the UV spectra of 5–NO2–saloH and 1-5 upon addition of  DNA 
(band studied in λ(nm), percentage of hyperchromism or hypochromism ΔA/Ao (%), blue– or red–
shift Δλ(nm)) and the corresponding DNA binding constants (Kb). 
Complex (λ, nm) (ΔA/Ao (%)
a
,  Δλ(nm)
b
) Kb (M
–1
) 
5–NO2–saloH [32] 366(+>
c
, +5), 430(+>, −5) 5.25(±0.25)×10
5
 
[Cd(5–NO2–salo)2(CH3OH)2], 1 373(-3, -4), 432(-21, -10) 3.45(±0.40)10
5 
[Cd(5–NO2–salo)2(phen)], 2 373(-1, -4), 432(-12.5, -7) 2.54(±0.42)10
5
 
[Cd(5–NO2–salo)2(dpamΗ)], 3 370(-3.5, -4), 430(-16.5, -6) 1.65(±0.10)10
6
 
[Cd3(5–NO2–salo)6(bipy)2], 4  373(-3.5, -4), 431(-14, -7) 5.29(±0.15)10
4
 
[Cd(5–NO2–salo)(neoc)(NO3)]2, 5 373(-0.5, -4), 431(-14.5, -7) 3.25(±0.20)10
4
 
a
 “+” denotes hyperchromism and “−” denotes hypochromism 
b 
“+” denotes bathochromism and “−” denotes hypochromism 
c 
“+>” denotes extreme hyperchromism 
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Table 4. Percentage of EB–DNA fluorescence emission quenching (ΔI/Io, 
%) and Stern–Volmer constants (KSV, in M
–1
) for 5–NO2–saloH and 1-5. 
Compound  ΔI/Io (%) KSV (M
–1
) 
5–NO2–saloH  72.5 2.22(±0.06)10
5
 
[Cd(5–NO2–salo)2(CH3OH)2], 1 86.7 1.41(±0.03)10
6
 
[Cd(5–NO2–salo)2(phen)], 2 80.4 7.37(±0.25)10
5
 
[Cd(5–NO2–salo)2(dpamΗ)], 3 67.1 1.21(±0.05)10
5
 
[Cd3(5–NO2–salo)6(bipy)2], 4 69.5 5.90(±0.25)10
5
 
[Cd(5–NO2–salo)(neoc)(NO3)]2, 5 62.4 5.86(±0.24)10
5
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(A) 
 
(B) 
 
Figure 1. 
1
H-NMR spectra of (A) 2 and (B) 4 in DMSO-d6. 
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Figure 2. Molecular structure of [Cd(5–NO2–salo)2(CH3OH)2] (1) with the displacement 
ellipsoids shown at the 50% probability level.  
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(A) (B) 
Figure 3. Molecular structure of (A) [Cd(5–NO2–salo)2(phen)]·2CH3OH∙H2O (2) and (B) [Cd(5–
NO2–salo)2(dpamH)] (3), with the displacement ellipsoids shown at the 50% probability level. 
The hydrogens are omitted for clarity. 
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Figure 4. Molecular structure of [Cd3(5–NO2–salo)6(bipy)2] (4) with the displacement ellipsoids 
shown at the 50% probability level. The hydrogens are omitted for clarity. 
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(A) (B) 
Figure 5. Thermoanalytical curves (TG/DTG-DTA) of (A) [Cd(5–NO2–salo)2(MeOH)2] (1) and 
(B) [Cd(5–NO2–salo)2(phen)]·2CH3OH∙H2O (2). 
D
ow
nl
oa
de
d 
by
 [P
ur
du
e U
niv
ers
ity
 L
ibr
ari
es
] a
t 2
2:0
5 0
2 N
ov
em
be
r 2
01
5 
32 
240 260 280 300 320
0.0
0.3
0.6
0.9
1.2
A
 (nm)
(A)
 
300 350 400 450 500
0.0
0.2
0.4
0.6
0.8
1.0
1.2
A
 (nm)
(B)
 
Figure 6. (A) UV spectra of CT DNA (1.4810–4 M) in buffer solution (150 mM NaCl and 15 
mM trisodium citrate at pH 7.0) in the absence or presence of 2 at increasing amounts. The arrow 
shows the changes upon increasing amounts of the complex. (B) UV spectra of DMSO solution 
(210–5 M) of 1 in the presence of increasing amounts of CT DNA. The arrows show the 
changes upon increasing amounts of CT DNA. 
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Figure 7. Relative viscosity (η/η0)
1/3
 of CT DNA (0.1 mM) in buffer solution (150 mM NaCl and 
15 mM trisodium citrate at pH 7.0) in the presence of 5–NO2–saloH and 1-5 with increasing 
amounts (up to r = [compound]/[DNA] = 0–0.35). 
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Figure 8. (A) Fluorescence emission spectra (λexcitation = 540 nm) for EB–DNA ([EB] = 20 μM, 
[DNA] = 26 μM) in buffer solution in the absence and presence of increasing amounts of 1 (up to 
r = 0.1). The arrow shows the changes of intensity upon increasing amounts of 1. (B) Plot of EB 
relative fluorescence emission intensity at λemission = 592 nm (%) vs r (r = [complex]/[DNA]) 
(150 mM NaCl and 15 mM trisodium citrate at pH = 7.0) in the presence of 5–NO2–saloH and 1-
5 (up to 13.3% of the initial EB–DNA fluorescence intensity for 1, 19.6% for 2, 32.9% for 3, 
30.5% for 4 and 37.6% for 5). 
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